Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer

Anticancer Research

Volumn 29, Issue 5, 2009, Pages 1715-1720

  Gadducci, Angiolo ^a   Cavazzana, Andrea ^b   Cosio, Stefania ^a   Di Cristofano, Claudio ^c   Tana, Roberta ^a   Fanucchi, Antonio ^a   Teti, Giancarlo ^a   Cristofani, Renza ^a   Genazzani, Andrea Riccardo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b ASL1 Massa Carrara   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Endometrial cancer; Haematogenous failure; Lymph vascular space involvement; Myometrial invasion; Recurrence

Indexed keywords

PLATINUM DERIVATIVE;

ABDOMINAL HYSTERECTOMY; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; METASTASIS; MYOMETRIUM; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RECURRENT CANCER; SALPINGOOOPHORECTOMY;

AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MYOMETRIUM; NEOPLASM INVASIVENESS; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 67650069978     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Heintz APM, Nyan HYS and Pecorelli S: Carcinoma of the corpus uteri. Int J Gynecol Obstet 95(Suppl 1): S105-S143, 2006.
2. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD and Graham JE: Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40: 55-65, 1991.
3. Inoue Y, Obata K, Abe K, Ohmura G, Doh K, Yoshioka T, Hoshiai H and Noda K: The prognostic significance of vascular invasion by endometrial carcinoma. Cancer 78: 1447-1451, 1996. (Pubitemid 26317865)
4. Bell JG, Minnick A, Reid GC, Judis J and Brownell M: Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma. Gynecol Oncol 66: 388-392, 1997. (Pubitemid 27388128)
5. Mariani A, Webb MJ, Keeney GL, Calori G and Podratz KC: Hematogenous dissemination in corpus cancer. Gynecol Oncol 80: 233-238, 2001.
6. Mariani A, Webb MJ, Keeney GL, Aletti G and Podratz KC: Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol 84: 437-442, 2002. (Pubitemid 34211872)
7. Mariani A, Webb MJ, Keeney GL, Lesnick TG and Podratz KC: Surgical stage I endometrial cancer: predictors of distant failure and death. Gynecol Oncol 87: 274-280, 2002. (Pubitemid 36034647)
8. Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R and Sakuragi N: Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol Oncol 96: 651-657, 2005. (Pubitemid 40255483)
9. Hamilton CA, Kapp DS and Chan JK: Clinical aspects of uterine papillary serous carcinoma. Curr Opin Obstet Gynecol 20: 26-33, 2008.
10. Orr JW Jr and Taylor PT Jr: Surgical management of endometrial cancer: how much is enough? Gynecol Oncol 109: 1-3, 2008.
11. Aalders J, Abeler V, Kolstad P and Onsrud M: Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56: 419-427, 1980. (Pubitemid 10018299)
12. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van de Steen-Banasik E, Beerman H and van Lent M: Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355: 1404-1411, 2000.
13. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, Pearlman A, Maiman MA and Bell JG: A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92: 744-751, 2004. (Pubitemid 38251372)
14. Kong A, Johnson N, Cornes P, Simera I, Collingwood M, Williams C and Kitchener H: Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev 2: CD003916; 2007.
15. Johnson N and Cornes P: Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis. Br J Ostet Gynaecol 114: 1313-1320, 2007. (Pubitemid 47609926)
16. Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC and Miller DS: Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 78: 63-69, 1991.
17. Podczaski E, Kaminski P, Gurski K, MacNeill C, Stryker JA, Singapuri K, Hackett TE, Sorosky J and Zaino R: Detection and patterns of treament failure in 300 consecutive cases of "early" endometrial cancer after primary surgery. Gynecol Oncol 47: 323-327, 1992.
18. Shumsky AG, Stuart GCE, Brasher P, Nation JG, Robertson DI and Sangkarat S: An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol 55: 229-233, 1994. (Pubitemid 124011464)
19. Reddoch JM, Burke TW, Morris M, Tornos C, Levenback C and Gershenson DM: Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol Oncol 59: 221-225, 1995.
20. Owen P and Duncan ID: Is there any value in the long-term follow-up of women treated for endometrial cancer? Br J Obstet Gynaecol 103: 710-713, 1996.
21. Salvesen HB, Akslen LA, Iversen T and Iversen OE: Recurrence of endometrial carcinoma and the value of routine follow-up. Br J Obstet Gynaecol 104: 1302-1307, 1997. (Pubitemid 27485500)
22. Gadducci A, Cosio S, Fanucchi A, Cristofani R and Genazzani AR: An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Anticancer Res 20: 1977-1984, 2000. (Pubitemid 30636168)
23. Wylie J, Irwin C, Pintilie M, Levin W, Manchul L, Milosevic M and Fyles A: Results of radical radiotherapy for recurrent endometrial cancer. Gynecol Oncol 77: 66-72, 2000. (Pubitemid 30217306)
24. Sartori E, Laface B, Gadducci A, Maggino T, Zola P, Landoni F and Zanagnolo V: Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) study. Int J Gynecol Cancer 13: 458-465, 2003. (Pubitemid 38220663)
25. DiSaia PJ, Creasman WT, Boronow RC and Blessing JA: Risk factors and recurrent patterns in stage I endometrial cancer. Am J Obstet Gynecol 151: 1009-1015, 1985. (Pubitemid 15039768)
26. Carey MS, O'Connell GJ, Johanson CR, Goodyear MD, Murphy KJ, Daya DM, Schepansky A, Peloquin A and Lumsden BJ: Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol 57: 138-144, 1995.
27. Anderson JM, Stea B, Hallum AV, Rogoff E and Childers J: High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. Int J Radiat Oncol 46: 417-425, 2000. (Pubitemid 30067792)
28. Rush S, Gal D, Potters L, Bosworth J and Lovecchio J: Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma. Int J Radiat Oncol Biol Phys 33: 851-854, 1995.
29. Fanning J, Nanavati PJ and Hilgers RD: Surgical staging and high dose rate brachytherapy for endometrial cancer: limiting external radiotherapy to node-positive tumors. Obstet Gynecol 87: 1041-1044, 1996. (Pubitemid 26159407)
30. Irwin C, Levin W, Fyles A, Pintilie M, Manchul L and Kirkbride P: The role of adjuvant radiotherapy in carcinoma of the endometrium-results in 550 patients with pathologic stage I disease. Gynecol Oncol 70: 247-254, 1998. (Pubitemid 28430938)
31. Corn BW, Lanciano RM, D'Agostino R, Kiggundu E, Dunton CJ, Purser P and Greven KM: The relationship of local and distant failure from endometrial cancer: defining a clinical paradigm. Gynecol Oncol 66: 411-416, 1997. (Pubitemid 27388132)
32. Soderini A, Anchezar JP and Sardi JE: Role of adjuvant radiotherapy (RT) in intermediate risk (1b G2-3-1C) endometrioid carcinoma (EC) after extended staging surgery (ESS). Preliminary reports of a randomised trial, Abstract P0147. Int J Gynecol Cancer 13(Suppl 1): 78, 2003.
33. Weigensberg IJ: Preoperative radiation therapy in stage I endometrial adenocarcinoma: II. Final report of a clinical trial. Cancer 53: 242-247, 1984.
34. Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, Thigpen JT and Benda JA: Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 24: 36-44, 2006.
35. Maggi R, Lissoni A, Spina F, Melpignano M, Zola P, Favalli G, Colombo A and Fossati R: Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomized trial. Br J Cancer 95: 266-271, 2006.
36. Greven K, Winter K, Underhill K, Fontenesci J, Cooper J and Burke T: Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 103: 155-159, 2006. (Pubitemid 44374683)
37. Hogberg T, Rosenberg P, Kristensen G, de Oliveira CF, de Pont Christensen R, Sorbe B, Lundgren C, Salmi T, Andersson H and Reed NS: A randomized phase-III study on adjuvant treatment with radiation (RT) + chemotherapy (CT) in early-stage high-risk endometrial cancer (NSGO-EC-9501/ EORTC 55991). J Clin Oncol 2007 ASCO Annual Meeting Proc Part I, Vol.25, No 18S (June 20 Suppl.), 5503, 2007.
38. Gal D, Recio FO, Zamurovic D and Tancer ML: Lymphvascular space involvment - a prognostic indicator in endometrial adenocarcinoma. Gynecol Oncol 42: 142-145, 1991.
39. Tsuruchi N, Kaku T, Kamura T, Tsukamoto N, Tsuneyoshi M, Akazawa K and Nakano H: The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining. Gynecol Oncol 57: 307-312, 1995.
40. Cohn DE, Horowitz NS, Mutch DG, Kim SM, Manolitsas T and Fowler JM: Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 87: 243-246, 2002.
41. Zaino RJ: Lymph-vascular space invasion in endometrial adenocarcinoma: confusion, confessions, and conclusions. Gynecol Oncol 87: 240-242, 2002. (Pubitemid 36034641)
42. Briët JM, Hollema H, Reesink N, Aalders JG, Mourits MJ, ten Hoor KA, Pras E, Boezen HM, van der Zee AG and Nijman HW: Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol 96: 799-804, 2005.
43. Viani GA, Patia BF, Pellizzon AC, De Melo MD, Novaes PE, Fogaroli RC, Conte MA and Salvajoli JV: High-risk surgical stage 1 endometrial cancer: analysis of treatment outcome. Radiat Oncol 1: 24-31, 2006.
44. Madom LM, Brown AK, Lui F, Moore RG, Granai CO and Disilvestro PA: Lower uterine segment involvement as a predictor for lymph node spread in endometrial carcinoma. Gynecol Oncol 107: 75-78, 2007. (Pubitemid 47464548)
45. Desrosiers L, Fadare O, Xiao ZF, Dresser K and Wang SA: Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium. Ann Diagn Pathol 12: 112-117, 2008. (Pubitemid 351312910)
46. Kwon JS, Carey MS, Cook EF, Qiu F and Paszat L: Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study. Int J Gynecol Cancer 17: 433-440, 2007. (Pubitemid 46426770)
47. Watanabe M, Aoki Y, Kase H, Fujita K and Tanaka K: Low-risk endometrial cancer: a study of pelvic lymph node metastasis. Int J Gynecol Cancer 13: 38-41, 2003. (Pubitemid 36292723)
48. Chi DS, Barakat RR, Palayekar MJ, Levine DA, Sonoda Y, Alektiar K, Brown CL and Abu-Rustum NR: The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer 18: 269-273, 2008.